Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review

Br J Cancer. 2007 Apr 10;96(7):1127-34. doi: 10.1038/sj.bjc.6603649.

Abstract

We combined information published worldwide on the seroprevalence of hepatitis B surface antigen (HbsAg) and antibodies against hepatitis C virus (anti-HCV) in 27 881 hepatocellular carcinomas (HCCs) from 90 studies. A predominance of HBsAg was found in HCCs from most Asian, African and Latin American countries, but anti-HCV predominated in Japan, Pakistan, Mongolia and Egypt. Anti-HCV was found more often than HBsAg in Europe and the United States.

Publication types

  • Meta-Analysis
  • Research Support, Non-U.S. Gov't
  • Systematic Review

MeSH terms

  • Carcinoma, Hepatocellular / epidemiology
  • Carcinoma, Hepatocellular / immunology
  • Carcinoma, Hepatocellular / virology*
  • Global Health
  • Hepacivirus / immunology*
  • Hepatitis B / epidemiology
  • Hepatitis B / immunology*
  • Hepatitis B Surface Antigens / blood
  • Hepatitis B virus / immunology*
  • Hepatitis C / epidemiology
  • Hepatitis C / immunology*
  • Hepatitis C Antibodies / blood
  • Humans
  • Liver Neoplasms / epidemiology
  • Liver Neoplasms / immunology
  • Liver Neoplasms / virology*
  • Seroepidemiologic Studies

Substances

  • Hepatitis B Surface Antigens
  • Hepatitis C Antibodies